In this study, the cohort with the greatest risk of death with distant relapse was comprised of patients with predominantly Stage III and Stage IV ER− breast cancer (Figure 4A); however, what is particularly interesting, is the association of these patients with low MCP‐1 expression in the primary tumour. The gene discussed is CCL2; the disease is breast carcinoma.